Catalyst Wire Dossier Catalyst Wire Dossier

AT-752

· Atea Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AT-752, covering 2024-03-05 to 2024-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of AT-752 in Patients With Dengue Infection [Phase 2]

See pricing